デフォルト表紙
市場調査レポート
商品コード
1316077

ポリメラーゼ連鎖反応市場:製品、技術、用途、エンドユーザー別-2023-2030年の世界予測

Polymerase Chain Reaction Market by Product, Technology, Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.49円
ポリメラーゼ連鎖反応市場:製品、技術、用途、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ポリメラーゼ連鎖反応の世界市場は、2023年に90億8,434万米ドル、CAGR12.53%で大きく成長し、2030年には208億2,007万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のポリメラーゼ連鎖反応市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.ポリメラーゼ連鎖反応の世界市場規模および予測は?

2.予測期間中、世界のポリメラーゼ連鎖反応市場を形成するCOVID-19の阻害要因と影響は?

3.ポリメラーゼ連鎖反応の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.ポリメラーゼ連鎖反応の世界市場における競争戦略は?

5.ポリメラーゼ連鎖反応の世界市場における技術動向と規制の枠組みは?

6.ポリメラーゼ連鎖反応の世界市場における主要ベンダーの市場シェアは?

7.ポリメラーゼ連鎖反応の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 感染症、がん、遺伝病の有病率の上昇
      • ライフサイエンスおよびバイオ医薬品の研究開発活動の増加
      • 飲食品業界での需要の拡大
    • 抑制要因
      • ポリマー連鎖反応に伴う高コスト
    • 機会
      • 高感度かつ最適化された高分子連鎖反応装置のイントロダクション
      • 分子生物学、生命科学、バイオテクノロジーにおける技術の進歩
    • 課題
      • 高分子連鎖反応システムの技術的限界
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 ポリメラーゼ連鎖反応市場:製品別

  • 消耗品と試薬
  • 楽器
  • ソフトウェアとサービス

第7章 ポリメラーゼ連鎖反応市場:技術別

  • デジタルPCR
  • リアルタイムPCR
  • 従来のPCR

第8章 ポリメラーゼ連鎖反応市場:用途別

  • 医学
    • 臨床
      • 血液検査
      • 腫瘍学検査
      • 病理検査
    • 法医学
    • 調査
  • 非医療用
    • 農業
    • 食べ物

第9章 ポリメラーゼ連鎖反応市場:エンドユーザー別

  • 学術調査機関
  • バイオテクノロジー企業
  • 調査受託機関・製造受託機関
  • 診断研究所
  • 病院

第10章 南北アメリカのポリメラーゼ連鎖反応市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のポリメラーゼ連鎖反応市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのポリメラーゼ連鎖反応市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化
    • 投資、資金調達
    • 受賞・表彰・拡大

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. POLYMERASE CHAIN REACTION MARKET RESEARCH PROCESS
  • FIGURE 2. POLYMERASE CHAIN REACTION MARKET SIZE, 2022 VS 2030
  • FIGURE 3. POLYMERASE CHAIN REACTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 6. POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. POLYMERASE CHAIN REACTION MARKET DYNAMICS
  • FIGURE 10. POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. POLYMERASE CHAIN REACTION MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. POLYMERASE CHAIN REACTION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. POLYMERASE CHAIN REACTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. POLYMERASE CHAIN REACTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. POLYMERASE CHAIN REACTION MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. POLYMERASE CHAIN REACTION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. POLYMERASE CHAIN REACTION MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 9. POLYMERASE CHAIN REACTION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. POLYMERASE CHAIN REACTION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. POLYMERASE CHAIN REACTION MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 14. POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 16. POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. POLYMERASE CHAIN REACTION MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. POLYMERASE CHAIN REACTION MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. POLYMERASE CHAIN REACTION MARKET SIZE, BY PATHOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. POLYMERASE CHAIN REACTION MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. POLYMERASE CHAIN REACTION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 23. POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. POLYMERASE CHAIN REACTION MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. POLYMERASE CHAIN REACTION MARKET SIZE, BY FOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. POLYMERASE CHAIN REACTION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. POLYMERASE CHAIN REACTION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. POLYMERASE CHAIN REACTION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION/ CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. POLYMERASE CHAIN REACTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. POLYMERASE CHAIN REACTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 323. POLYMERASE CHAIN REACTION MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 324. POLYMERASE CHAIN REACTION MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 325. POLYMERASE CHAIN REACTION MARKET LICENSE & PRICING
目次
Product Code: MRR-205091A8892C

The Global Polymerase Chain Reaction Market is forecasted to grow significantly, with a projected USD 9,084.34 million in 2023 at a CAGR of 12.53% and expected to reach a staggering USD 20,820.07 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Polymerase Chain Reaction Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Polymerase Chain Reaction Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables & Reagents, Instruments, and Software & Services. The Instruments commanded largest market share of 51.75% in 2022, followed by Software & Services.

Based on Technology, market is studied across Digital PCR, Real-time PCR, and Traditional PCR. The Real-time PCR commanded largest market share of 52.34% in 2022, followed by Digital PCR.

Based on Application, market is studied across Medical and Non-Medical. The Medical is further studied across Clinical, Forensics, and Research. The Clinical is further studied across Blood screening, Oncology testing, and Pathology testing. The Non-Medical is further studied across Agriculture and Food. The Medical commanded largest market share of 63.23% in 2022, followed by Non-Medical.

Based on End-User, market is studied across Academic Research Institutes, Biotechnology Companies, Contract Research Organization/ Contract Manufacturing Organization, Diagnostic Laboratories, and Hospitals. The Biotechnology Companies commanded largest market share of 28.23% in 2022, followed by Contract Research Organization/ Contract Manufacturing Organization.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 37.96% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Polymerase Chain Reaction Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Polymerase Chain Reaction Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Polymerase Chain Reaction Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Polymerase Chain Reaction Market?

4. What is the competitive strategic window for opportunities in the Global Polymerase Chain Reaction Market?

5. What are the technology trends and regulatory frameworks in the Global Polymerase Chain Reaction Market?

6. What is the market share of the leading vendors in the Global Polymerase Chain Reaction Market?

7. What modes and strategic moves are considered suitable for entering the Global Polymerase Chain Reaction Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Polymerase Chain Reaction Market, by Product, 2022 vs 2030
  • 4.3. Polymerase Chain Reaction Market, by Technology, 2022 vs 2030
  • 4.4. Polymerase Chain Reaction Market, by Application, 2022 vs 2030
  • 4.5. Polymerase Chain Reaction Market, by End-User, 2022 vs 2030
  • 4.6. Polymerase Chain Reaction Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the prevalence of infectious diseases, cancer, and genetic disease
      • 5.1.1.2. Increasing life science and biopharmaceutical research and development activities
      • 5.1.1.3. Growing demand in the food & beverage industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with a polymer chain reaction
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of high sensitive and optimized polymer chain reaction instruments
      • 5.1.3.2. Technological advancements in molecular biology, life sciences, and biotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of polymer chain reaction systems
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Polymerase Chain Reaction Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables & Reagents
  • 6.3. Instruments
  • 6.4. Software & Services

7. Polymerase Chain Reaction Market, by Technology

  • 7.1. Introduction
  • 7.2. Digital PCR
  • 7.3. Real-time PCR
  • 7.4. Traditional PCR

8. Polymerase Chain Reaction Market, by Application

  • 8.1. Introduction
  • 8.2. Medical
    • 8.2.1. Clinical
      • 8.2.1.1. Blood screening
      • 8.2.1.2. Oncology testing
      • 8.2.1.3. Pathology testing
    • 8.2.2. Forensics
    • 8.2.3. Research
  • 8.3. Non-Medical
    • 8.3.1. Agriculture
    • 8.3.2. Food

9. Polymerase Chain Reaction Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Biotechnology Companies
  • 9.4. Contract Research Organization/ Contract Manufacturing Organization
  • 9.5. Diagnostic Laboratories
  • 9.6. Hospitals

10. Americas Polymerase Chain Reaction Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Polymerase Chain Reaction Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Polymerase Chain Reaction Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Genomadix Inc. announces know-how license agreement with Mayo Clinic
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Next Generation of qPCR Reagents push the boundaries of performance
      • 13.3.2.2. Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.
      • 13.3.2.3. Bosch's Vivalytic platform offering new PCR rapid test for MRSA
      • 13.3.2.4. GenScript launches monkeypox PCR test
    • 13.3.3. Investment & Funding
      • 13.3.3.1. Mumbai-based Rivaara Labs raises funding from Amicus, Kotak investment advisors
      • 13.3.3.2. Molbio Diagnostics raises $85 mn from Temasek at unicorn valuation
      • 13.3.3.3. Zymo Research to invest in Star Array for PCR platform development
      • 13.3.3.4. North York life sciences company gets $2.5M from provincial fund to help produce PCR test chemicals
    • 13.3.4. Award, Recognition, & Expansion
      • 13.3.4.1. Roche expands the COVID-19 PCR test portfolio to the new cobas 5800 System in countries accepting the CE Mark

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing